Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Thiogenesis Therapeutics Corp (TSE:TTI)
TSXV:TTI
RESEARCH TOOLSreports
Holding TSE:TTI?
Track your performance easily
TTI Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.64 - C$1.06
Previous CloseC$0.7
Volume3.00K
Average Volume (3M)29.23K
Market Cap
C$29.10M
Enterprise ValueC$23.57M
Total Cash (Recent Filing)$5.52M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.12
Next Earnings
Nov 18, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding45,495,575
10 Day Avg. Volume12,870
30 Day Avg. Volume29,228
Standard Deviation0.12
R-Squared0.05
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)5.83
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-4.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-5.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Thiogenesis Therapeutics Corp News
PremiumCompany Announcements
Thiogenesis Secures Key European Patent
PremiumCompany Announcements
Thiogenesis Boosts Investor Relations with New Partnership
PremiumCompany Announcements
Thiogenesis Discusses Breakthrough Treatment at Symposium
PremiumCompany Announcements
Thiogenesis Advances Pediatric NASH Treatment Trial
PremiumCompany Announcements
Thiogenesis Advances Leigh Syndrome Treatment Trial
PremiumCompany Announcements
Thiogenesis Advances MELAS Treatment TrialOptions Prices
Currently, No data available
---
Ownership Overview
26.80% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
73.20% Public Companies and
Individual Investors
TTI FAQ
What was Thiogenesis Therapeutics Corp’s price range in the past 12 months?
Thiogenesis Therapeutics Corp lowest stock price was C$0.64 and its highest was C$1.06 in the past 12 months.
What is Thiogenesis Therapeutics Corp’s market cap?
Currently, no data Available
When is Thiogenesis Therapeutics Corp’s upcoming earnings report date?
Thiogenesis Therapeutics Corp’s upcoming earnings report date is Nov 18, 2024 which is in 5 days.
How were Thiogenesis Therapeutics Corp’s earnings last quarter?
Thiogenesis Therapeutics Corp released its earnings results on Aug 23, 2024. The company reported -C$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.01.
Is Thiogenesis Therapeutics Corp overvalued?
According to Wall Street analysts Thiogenesis Therapeutics Corp’s price is currently Overvalued.
Does Thiogenesis Therapeutics Corp pay dividends?
Thiogenesis Therapeutics Corp does not currently pay dividends.
What is Thiogenesis Therapeutics Corp’s EPS estimate?
Thiogenesis Therapeutics Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Thiogenesis Therapeutics Corp have?
Thiogenesis Therapeutics Corp has 41,569,214 shares outstanding.
What happened to Thiogenesis Therapeutics Corp’s price movement after its last earnings report?
Thiogenesis Therapeutics Corp reported an EPS of -C$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.74%.
Which hedge fund is a major shareholder of Thiogenesis Therapeutics Corp?
Currently, no hedge funds are holding shares in TSE:TTI
---
Thiogenesis Therapeutics Corp Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
-98.58%
Trailing 12-Months
Asset Growth
7.78%
Trailing 12-Months
Company Description
Thiogenesis Therapeutics Corp
Thiogenesis Therapeutics Corp is an early stage biotech company. It is developing novel drug formulations that act as precursors to cysteamine, which is a small aminothiol compound that is endogenous in humans in small quantities.
---
Technical Analysis
---